Skip to main content
. 2014 Nov 14;4:7063. doi: 10.1038/srep07063

Table 3. Multiple factor analysis of NCAM1 related pathway mutations and clinical parameters per tumour.

  Dim.1 Dim.2 Dim.3 Dim.4 Dim.5
A. No. Mutations in NCAM Pathways* 0.103 0.892 0.910 0.367 0.321
Stages 0.804 0.459 0.381 0.833 0.725
Receptor status 0.379 0.356 0.406 0.471 0.641
Patient status 0.868 0.159 0.050 0.106 0.159
% Variance explained 7.618 5.699 5.635 4.944 4.694
B. No. Mutations Unique to NCAM Pathways∧ 0.264 0.899 0.894 0.304 0.300
Stage 0.791 0.413 0.380 0.877 0.752
Receptor status 0.389 0.427 0.411 0.429 0.610
Patient status 0.851 0.083 0.158 0.168 0.221
% Variance explained 7.716 5.816 5.534 4.941 4.743

*mutation count for all genes in NCAM pathways.

∧mutation count for genes unique to NCAM pathways, and not in collagen or ECM pathways.